David Low
Stock Analyst at UBS
(3.54)
# 2,243
Out of 5,028 analysts
309
Total ratings
51.1%
Success rate
4.6%
Average return
Main Sectors:
Stocks Rated by David Low
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: ANN Ansell Limited | Reiterated: Hold | $38.70 | $45.16 | -14.30% | 18 | Oct 4, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Hold | $21.20 | $18.75 | +13.07% | 34 | Sep 23, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $22.00 | $15.54 | +41.57% | 6 | Sep 23, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Buy | $181.00 | $178.57 | +1.36% | 32 | Sep 2, 2026 | |
| ASX: REG Regis Healthcare Limited | Reiterated: Hold | $6.75 → $5.95 | $4.43 | +34.31% | 16 | Sep 2, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Hold | $42.90 → $55.60 | $54.65 | +1.74% | 21 | Aug 28, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Hold | $106.00 → $150.00 | $130.15 | +15.25% | 22 | Aug 19, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Buy | n/a | $32.06 | - | 25 | Aug 7, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.25 → $3.40 | $2.15 | n/a | 12 | Aug 27, 2025 | |
| ASX: NAN Nanosonics Limited | Reiterated: Sell | $4.00 → $3.90 | $2.92 | n/a | 20 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.30 | $0.93 | n/a | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47.77 → $45.29 | $19.22 | n/a | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.62 | $0.43 | n/a | 26 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $282.00 → $300.00 | $159.85 | n/a | 5 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $290 → $310 | $222.86 | n/a | 43 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32.00 → $35.00 | $46.57 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.95 → $0.78 | $0.22 | n/a | 4 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.87 | n/a | 7 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $30.92 | n/a | 1 | Dec 4, 2019 |
Ansell Limited
Oct 4, 2026
Reiterated: Hold
Price Target: $38.70
Current: $45.16
Upside: -14.30%
Sonic Healthcare Limited
Sep 23, 2026
Reiterated: Hold
Price Target: $21.20
Current: $18.75
Upside: +13.07%
Telix Pharmaceuticals Limited
Sep 23, 2026
Reiterated: Buy
Price Target: $22.00
Current: $15.54
Upside: +41.57%
CSL Limited
Sep 2, 2026
Reiterated: Buy
Price Target: $181.00
Current: $178.57
Upside: +1.36%
Regis Healthcare Limited
Sep 2, 2026
Reiterated: Hold
Price Target: $6.75 → $5.95
Current: $4.43
Upside: +34.31%
Ramsay Health Care Limited
Aug 28, 2026
Reiterated: Hold
Price Target: $42.90 → $55.60
Current: $54.65
Upside: +1.74%
Cochlear Limited
Aug 19, 2026
Reiterated: Hold
Price Target: $106.00 → $150.00
Current: $130.15
Upside: +15.25%
ResMed Inc.
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $32.06
Upside: -
Integral Diagnostics Limited
Aug 27, 2025
Reiterated: Buy
Price Target: $3.25 → $3.40
Current: $2.15
Upside: n/a
Nanosonics Limited
Aug 27, 2025
Reiterated: Sell
Price Target: $4.00 → $3.90
Current: $2.92
Upside: n/a
Aug 27, 2025
Reiterated: Hold
Price Target: $1.30
Current: $0.93
Upside: n/a
Aug 27, 2025
Reiterated: Hold
Price Target: $47.77 → $45.29
Current: $19.22
Upside: n/a
Aug 25, 2025
Reiterated: Sell
Price Target: $0.62
Current: $0.43
Upside: n/a
Aug 14, 2025
Reiterated: Hold
Price Target: $282.00 → $300.00
Current: $159.85
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $290 → $310
Current: $222.86
Upside: n/a
Jun 3, 2025
Reiterated: Hold
Price Target: $32.00 → $35.00
Current: $46.57
Upside: n/a
Mar 2, 2025
Reiterated: Buy
Price Target: $0.95 → $0.78
Current: $0.22
Upside: n/a
Aug 23, 2021
Reiterated: Hold
Price Target: n/a
Current: $12.87
Upside: n/a
Dec 4, 2019
Downgraded: Hold
Price Target: n/a
Current: $30.92
Upside: n/a